These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe. Vesikari T; Itzler R; Karvonen A; Korhonen T; Van Damme P; Behre U; Bona G; Gothefors L; Heaton PM; Dallas M; Goveia MG Vaccine; 2009 Dec; 28(2):345-51. PubMed ID: 19879226 [TBL] [Abstract][Full Text] [Related]
4. RotaTeq vaccine adverse events and policy considerations. Geier DA; King PG; Sykes LK; Geier MR Med Sci Monit; 2008 Mar; 14(3):PH9-16. PubMed ID: 18301365 [TBL] [Abstract][Full Text] [Related]
5. Addition of history of intussusception as a contraindication for rotavirus vaccination. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(41):1427. PubMed ID: 22012117 [TBL] [Abstract][Full Text] [Related]
7. RotaTeq: a new oral rotavirus vaccine. Med Lett Drugs Ther; 2006 Jul; 48(1240):61-3. PubMed ID: 16874281 [No Abstract] [Full Text] [Related]
8. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. American Academy of Pediatrics Committee on Infectious Diseases Pediatrics; 2007 Jan; 119(1):171-82. PubMed ID: 17200286 [TBL] [Abstract][Full Text] [Related]
10. [Recommendations for the use of rotavirus vaccines in industrialized countries]. Franco E Ig Sanita Pubbl; 2006; 62(6):697-700. PubMed ID: 17256023 [TBL] [Abstract][Full Text] [Related]
14. [Active immunization against acute gastro-enteritis among young children, caused by rotaviruses]. Magdzik W Przegl Epidemiol; 2007; 61(4):723-31. PubMed ID: 18572504 [TBL] [Abstract][Full Text] [Related]
15. Rotavirus vaccines: entering a new stage of deployment. Nakagomi O; Cunliffe NA Curr Opin Infect Dis; 2007 Oct; 20(5):501-7. PubMed ID: 17762784 [TBL] [Abstract][Full Text] [Related]
16. The human rotavirus vaccine RIX4414 in infants: a review of safety and tolerability. Cheuvart B; Friedland LR; Abu-Elyazeed R; Han HH; Guerra Y; Verstraeten T Pediatr Infect Dis J; 2009 Mar; 28(3):225-32. PubMed ID: 19209095 [TBL] [Abstract][Full Text] [Related]
17. A short report on highlights of world-wide development of RIX4414: an European experience. Vesikari T; Karvonen A; Puustinen L; Szakal ED; Zeng SQ; Delem A; De Vos B Vaccine; 2006 May; 24(18):3779. PubMed ID: 16581159 [No Abstract] [Full Text] [Related]
18. A critical time for rotavirus vaccines: a review. Cunliffe NA; Nakagomi O Expert Rev Vaccines; 2005 Aug; 4(4):521-32. PubMed ID: 16117709 [TBL] [Abstract][Full Text] [Related]